← Back to Clinical Trials
Recruiting NCT07463079

NCT07463079 Clinical Evaluation of a Soothing Moisturizing Lotion in Individuals With Atopic Eczema

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07463079
Status Recruiting
Phase
Sponsor USMARI Research & Innovation Centre
Condition Eczema
Study Type INTERVENTIONAL
Enrollment 15 participants
Start Date 2026-02-01
Primary Completion 2026-05-30

Trial Parameters

Condition Eczema
Sponsor USMARI Research & Innovation Centre
Study Type INTERVENTIONAL
Phase N/A
Enrollment 15
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2026-02-01
Completion 2026-05-30
Interventions
Moisturizing lotion

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

To investigate the safety and efficacy of the moisturizing lotion in improving eczema symptoms among individuals with atopic eczema in Malaysia. The study duration is 4 weeks and the skin assessment will be carried out at baseline and week 4. The main questions this study aims to answer are: 1. To investigate the safety of the moisturizing lotion for individuals with atopic eczema in Malaysia. 2. To determine the efficacy of the moisturizing lotion in improving eczema lesions among individuals with atopic eczema in Malaysia. 3. To assess the participants' satisfaction after using the moisturizing lotion.

Eligibility Criteria

Inclusion Criteria: * Healthy Malaysian women and men * Age above 18 years old * Clinically diagnosed with eczema with mild to moderate severity on any parts of the body as evaluated by Eczema Area and Severity Index (EASI) (score 10-20). Exclusion Criteria: * History of allergies or adverse reactions to moisturizers or components of the specific products being tested * History of chronic allergies * Pregnant, breastfeeding women, or those planning pregnancy during the study period * Participants with documented autoimmune diseases. * Currently undergoing or requiring active drug treatment for atopic dermatitis or eczema * Use of any medication (topical or systemic) that could interfere with the study aim (e.g. corticosteroids, calcineurin inhibitors, methotrexate) 3 months prior to the start of the study treatment and throughout the study * Current participation in another interventional clinical study * Presence of dermatological or systemic disorder other than eczema that could inte

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology